ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

RFP: Sole Source

May 12, 2000

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011